NY-ESO-1 Antigen-Reactive T Cell Receptors Exhibit Diverse Therapeutic Capability

International Journal of Cancer - United States
doi 10.1002/ijc.27792
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Quantifying and Imaging NY-ESO-1/LAGE-1-Derived Epitopes on Tumor Cells Using High Affinity T Cell Receptors

Journal of Immunology
AllergyImmunology
2006English

Identification of CD4+ T Cell Epitopes From NY-ESO-1 Presented by HLA-DR Molecules

Journal of Immunology
AllergyImmunology
2000English

Induction of Primary NY-ESO-1 Immunity: CD8+ T Lymphocyte and Antibody Responses in Peptide-Vaccinated Patients With NY-ESO-1+ Cancers

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2000English

Regulatory T Cell Depletion Enhances Tumor Specific CD8 T-Cell Responses, Elicited by Tumor Antigen NY-ESO-1b in Hepatocellular Carcinoma Patients, in Vitro

International Journal of Oncology
Cancer ResearchOncology
2010English

Differential Presentation of a Soluble Exogenous Tumor Antigen, NY-ESO-1, by Distinct Human Dendritic Cell Populations

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2002English

Tetramer Guided, Cell Sorter Assisted Production of Clinical Grade Autologous NY-ESO-1 Specific CD8+ T Cells

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Multiepitope CD8+ T Cell Response to a NY-ESO-1 Peptide Vaccine Results in Imprecise Tumor Targeting

Journal of Clinical Investigation
Medicine
2002English

NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer

PLoS ONE
Multidisciplinary
2012English

Human and Mouse Type I Natural Killer T Cell Antigen Receptors Exhibit Different Fine Specificities for CD1d-Antigen Complex

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy